Piper Sandler Companies PIPR

Key data

The business

Piper Sandler is a mid-market investment bank. It advises companies on selling themselves and merging, underwrites and places their stock and bonds, runs a municipal finance desk for state and local governments, and trades equities and fixed income for institutions. The fees come deal by deal: a percentage of an acquisition, a spread on an offering, a commission on a block of shares. Nothing under it recurs like a subscription, which is why revenue swings with the deal calendar. The moat is people and relationships, the banker who has sold three companies in a niche gets the fourth call, and Piper has bought its way deeper into healthcare, financial services and energy over the past decade. What a client actually buys is a named banker's judgment and contact list, not the firm's logo, which is both the asset and the risk: the whole franchise can walk to a competitor.

The numbers

The last five quarters show a business climbing out of a shallow trough, with the year-end quarter doing the heavy lifting.

Revenue rose 26% and net income 61% in the second quarter from a year earlier, and operating margin nearly doubled to 20% from 12%, the signature of a fee business where a fixed banker payroll suddenly covers far more revenue. The fourth quarter is always the monster, $667M and $1.60 of earnings last December as deals close and bonuses settle, so read the run rate off the first two quarters, not off December. The third-quarter print flagged as the thing to watch last month has not landed yet, Q3 does not close until the end of September, so the strong first half it was measured against still stands untested.

Diluted earnings went from $1.63 in 2022 to $3.96 in 2025, about 34% a year, but that is the arithmetic of a recovery off a bad year, not steady compounding, and 2021 already earned $4.11 in the last boom. Revenue grew a calmer 11% a year. Share count is the quiet leak: up 4.8% over three years even after the firm spent $125M buying stock back in 2025, because the stock pay used to keep bankers issues more than the buyback retires. Free cash flow per share swung from negative $3.77 in 2022 to $9.81 last year. Judge the multiple on mid-cycle earnings, somewhere between the 2023 trough and this recovery, not on the last twelve months.

Two forces drive the recovery, and the lens separates them: operating leverage on the banker base, and a newer tailwind from interest the firm earns on its own cash, which more than tripled year over year in the second quarter and spiked to $42M in December on year-end balances. What this memo believes that the tape does not is that this interest income and a wider advisory platform have quietly raised the earnings floor; the print that settles it is the operating margin in the next genuinely slow quarter.

Management

Insiders sold and did not buy: thirteen sales worth $11.4M over the past year against zero purchases, roughly a fifth of a percent of the company, led by vice chairman Jonathan Doyle unloading about $5M in early May. The feed does not mark which of those were pre-scheduled 10b5-1 sales and which were discretionary, so read the signal as soft rather than loud. Capital allocation tells a cleaner story: management bought $187M of stock back in 2022 at about $32 and $71M in 2023 at $36, excellent timing, but 2025's $125M went out near $75, close to today's price and last year's highs, so the recent buyback is capital returned rather than value created. CEO pay ran $11M in 2025, under 4% of net income and mostly bonus and stock, which is not the number that breaks this.

How it fails or surprises you

The cycle turns and the payroll cannot follow. Advisory revenue can halve in a bad year, as 2023's $1.24 of earnings against 2025's $3.96 shows, and the banker comp that made this year's margin cannot flex down fast without the bankers leaving. The print that shows it first is advisory revenue and the comp ratio in a single soft quarter.

The share count keeps leaking. Diluted shares rose 4.8% in three years despite real buyback dollars, because stock is the currency that retains talent. Paying 18 times earnings while the count creeps upward means part of the recovery is quietly financed by owners. Watch diluted shares outstanding each quarter against buyback spend.

The floor is higher than the tape thinks (right tail). If the next genuinely slow quarter still prints double-digit operating margins, near the 18 to 20% of the softer first half rather than the 12% of a year ago, the market is pricing a boutique cyclical while owning a structurally more profitable one. The interest income and the enlarged platform would be the reason, and a re-rate follows the proof.

Closing thoughts

This is a cyclical priced roughly fairly, so the edge here is small and honest about it. The distribution the evidence implies is wide and symmetric around a business earning well right now: on one side the deal calendar cools and the multiple compresses on falling earnings the way boutiques always de-rate, on the other the interest income and a bigger advisory bench prove the floor has lifted and today's 18 times turns out to have been paid on a new base, not a peak. The left tail is the one to respect, because a securities firm bought after its best half in years and near the top of its usual multiple is the classic way to lose money slowly, and the fatter tail depends on whether the next weak quarter still holds its margin.

The bet stays what it was: companies keep hiring Piper to advise their mergers and raise their money, the bankers stay, and the deal recovery runs. What breaks it is the deal calendar stalling with the comp bill fixed, and the one pair of numbers that tells you first is quarterly advisory revenue against the operating margin it drops through. Buy this only if you believe the cycle has years left, which is a view about the world, not about Piper.